Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.
about
ddClone: joint statistical inference of clonal populations from single cell and bulk tumour sequencing data.Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrationsReconstructing metastatic seeding patterns of human cancers.Origins of lymphatic and distant metastases in human colorectal cancer.Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.Advances in understanding tumour evolution through single-cell sequencing.Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer.Tumor evolution: Linear, branching, neutral or punctuated?Catch my drift? Making sense of genomic intra-tumour heterogeneity.A population genetics perspective on the determinants of intra-tumor heterogeneity.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.ReMixT: clone-specific genomic structure estimation in cancer.High grade serous ovarian carcinomas originate in the fallopian tube.ClonEvol: clonal ordering and visualization in cancer sequencing.Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.VaDiR: an integrated approach to Variant Detection in RNA.Lymph Node Metastases in Colon Cancer are Polyclonal.Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors.Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.E-scape: interactive visualization of single-cell phylogenetics and cancer evolution.Determinants and clinical implications of chromosomal instability in cancer.Tumour heterogeneity and resistance to cancer therapies.Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.Phylogenetic Copy-Number Factorization of Multiple Tumor Samples.Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer.Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological MalignanciesCentrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneityEvaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
P2860
Q31168783-01919A6D-0077-43D7-B75E-BCE18AEA3ED6Q33810500-F8DC9FBB-0D91-4F92-B807-F87F78DFEF5FQ37622594-67E25365-D8E3-4277-B583-812E43DA9F60Q38373329-207358AF-2DC8-4468-A4F6-B1E8081946F1Q38601861-6B96B13D-C7DE-4C39-B975-11573603B0C5Q38715123-7BA68F4E-A9E3-474B-8BF8-F3E9361C12F1Q38758032-76339941-2EF8-4081-8C70-60C057356F97Q38762835-18779845-FD2A-4D78-A0CD-AFB2C3AEBAFFQ39007635-B6E67A1E-3ED8-4A6E-93A5-90BD9CE73F84Q39030893-A5BC6E9B-12CF-4A37-8B0E-1EC29D806F4FQ39169154-9FF70587-9DBC-456A-8DCC-3AFB4A47A5EDQ39441988-56F6A319-4816-4E57-923E-07E38CDE091EQ41147208-2C8C1278-054F-4889-83F7-B90D5145E988Q42645872-6A4F9F4A-F527-489B-B2DF-4761A1B25A95Q42696942-7F8F67FA-13D0-4329-9A3B-3DB8A0B36D7DQ47200971-84337285-F8E8-4FDE-8906-310D6E770C04Q47266519-363E54DD-E0F9-41DD-8842-4CF46A055D3AQ47370965-1FBF60D1-D9D7-4FCE-AFBA-F18CA80C4975Q47445797-CE1AA0FC-5690-407F-8CB4-0C05DAB92774Q47738170-D544B0EB-230F-4A1E-935E-D23E75F40EEBQ48124146-B9DC2716-64BE-4D14-A3A8-0A7D06EC19F7Q48357851-26367197-A91F-48BE-AC4F-7F2B2E877AA2Q49347721-E7CF7C3C-E352-4640-8C3D-2F7328587669Q50112440-54FB369D-5D01-4F62-A388-0EEE2126A140Q52321029-77BD051B-2DEB-49C2-A8C2-8FD03B0D347FQ52586602-6CC15687-56CD-4223-9863-9101737F6EF7Q53499541-7FDC78A2-32D4-4699-A31E-3631E19C85AAQ53730678-6627D18E-02E8-4CA1-8A70-F6B15F84D6A8Q54122669-9A66CEB2-3873-466A-BBE4-0DBFF851A68EQ54277914-D94DCC26-BDF8-480F-9280-31C1F3C66C55Q55247640-339E2768-0D86-497D-9CDB-05DE53350B07Q56365972-62C26B5D-959B-46B9-B824-AB804F1A0349Q58132668-C98B9226-CD6B-4AB4-848A-61E9F1FB2BAFQ58708119-827CCE2F-24BC-4978-9752-36D07A24FDC8
P2860
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@en
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@nl
type
label
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@en
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@nl
prefLabel
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@en
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Divergent modes of clonal spre ...... h-grade serous ovarian cancer.
@en
P2093
Adrian Wan
Alexandre Bouchard-Côté
Ali Bashashati
Allen W Zhang
Andrew Roth
Anthony Karnezis
C Blake Gilks
Cydney B Nielsen
David G Huntsman
P2860
P2888
P304
P356
10.1038/NG.3573
P407
P577
2016-05-16T00:00:00Z